Transplacental Transfer of Acquired Factor VIII: C Inhibitor

Thromb Haemost 1987; 57(01): 126
DOI: 10.1055/s-0038-1651079

Letters to the Editor

Schattauer GmbH Stuttgart

Authors

Emmett H Broxson

Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, 80262, USA
Wm E Hathaway

Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, 80262, USA

References
1 Reece EA, Romero R, Hobbins J. Coagulopathy associated with factor VIII inhibitor. A literature review. J Reprod Med 1984; 29: 53-58
2 Frick PG. Hemophilia-like disease following pregnancy with transplacental transfer of an acquired circulating anticoagulant. Blood 1953; 8: 598-608
3 Shitamoto BS, Leslie KO, Galloway WB. Postpartum hemophilia. Am J Clin Pathol 1982; 78: 789-791
4 Simone JV, Vanderheiden J, Abildgaard CF. A semiautomatic one stage factor VIII assay with a commercially prepared standard. J Lab Clin Med 1967; 69: 706-712
5 Kasper CK, Aledort LM. et al A more uniform measurement of factor VIII inhibitors. Thrombos Diathes Haemorrh 1975; 34: 869-872
6 Coller BS, Hultin MB. et al Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood 1981; 58: 619-623
7 Biggs R, Austen D EG. et al The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Br J Haematol 1972; 23: 137-155
8 Michiels JJ, Bosch LJ. et al Factor VIII inhibitor postpartum. Scand J Haematol 1978; 20: 97-107